SynGAP Research Fund becomes CURE SYNGAP1, sharpening its focus on treatment for a rare brain disorder
The SynGAP Research Fund has formally rebranded as CURE SYNGAP1 to better communicate its mission of developing treatments for SYNGAP1-related disorders, a rare genetic condition affecting brain development. Leadership and scientific strategy remain unchanged.








